We are thrilled to announce that Postman, the world's leading API platform, has successfully raised $433 million in a recent funding round. This significant investment underscores the growing demand for efficient API development tools and the vital role that Postman plays in the world of software development. With over 30 million developers and 500,000 organizations tapping into our platform, we're committed to simplifying every step of API creation and enhancing collaboration among teams, ultimately enabling them to build better APIs—faster. The funds will be strategically allocated to accelerate product innovation, expand our global reach, and continue supporting our robust community of developers. As businesses increasingly rely on APIs to drive digital transformation, Postman stands at the forefront of this evolution, providing the tools and resources needed to succeed in a competitive landscape. Our customers continue to achieve remarkable milestones with the help of our platform, and we’re excited to see what they will accomplish next. We invite you to join our journey and explore exciting career opportunities at Postman—be a part of a team that is shaping the future of API development. Check out our open positions at https://www.postman.com/careers/ and consider contributing to the incredible innovations that define our work. In a world where APIs are essential for connectivity and innovation, Postman is not just keeping pace; we are setting the standard.
Postman Secures $433M in Funding to Power Global API Innovation Revolution
Get the full Postman company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Webclew
Webclew helps digital domain owners regain control over data collection and compliance. - Discover tracking without valid consent. - Keep policies up-to-date. - Ensure vendors comply with data processing agreements. Our SaaS solution monitors your domains & apps to turn a flurry of web requests into a comprehensive view on online data collection and compliance threats. We provide a fully automated process so our customers can focus on resolving actionable alerts.
$1.9M Seed
today
Capital B
Capital B is a nonprofit local/national news organization for Black audiences. Cofounded by veteran news leaders Lauren Williams and Akoto Ofori-Atta, Capital B deliver quality, trustworthy, original reporting to Black people across the country.
$17.8M Unknown
today
Prisma Labs, Inc.
Prisma Labs is a mobile technology company specialising in deep learning-related products. Our goal is to move forward mobile photography and video creation to the next level using neural networks, deep learning and computer vision technics. We aim to create new ways for people to express their emotions through the camera.
$100.0K Unknown
today
Atro
Atro is a venture-backed cybersecurity platform for SMBs, MSPs, and insurance providers that makes protecting sensitive data an entirely stress-free experience. Built by a team of world-class experts who understand the struggles of starting small, Atro is dedicated to solving cyber disparities with solutions that are accessible to every business owner. Want to see Atro in action? Watch our product demos here: https://www.youtube.com/@Atro-Cybersecurity/playlists
$100.0K Unknown
today
3D Bio-Tissues ltd - powered by BSF plc
3D Bio-tissues (3DBT) is a biotechnology company redefining the efficiency of cell-based therapies and cellular agriculture. We specialize in the development of macromolecular crowders—simple, powerful media additives designed to mimic the natural physiological environment, accelerating growth and significantly reducing operational costs. At the core of our innovation is a commitment to making complex biology scalable. By optimizing the way cells interact with their environment, we help our partners move from lab-scale success to industrial-scale reality. Our Core Solutions: CityMix™ | Transforming Cultivated Meat: The biggest barrier to cultivated meat is the cost of media. CityMix™ is a patented macromolecular crowder that reduces the requirement for expensive growth factors and supplements. It enables higher yields and faster production times, making sustainable, slaughter-free meat commercially viable. CytoBoost™ | Powering Biopharmaceutical Science: Precision matters in bioprocessing. CytoBoost™ enhances the performance of cell lines used in drug discovery and therapeutic production. It stabilizes proteins and improves cellular productivity without complex media reformulations. CytoBoost™ REVIVE | The Post-Thaw Cell Enabler: Cryopreservation is a critical stressor for cells. CytoBoost™ REVIVE is specifically formulated to act as a post-thaw enabler, minimizing the "lag phase" and maximizing cell viability and recovery. It ensures that your research or production starts with the strongest biological foundation possible. Why 3DBT? We don’t just provide additives; we provide the tools for the next generation of life sciences. Whether you are aiming to lower the price of a cultivated steak or increase the yield of a life-saving biologic, our macromolecular crowding technology is the "plug-and-play" solution your bioprocess needs.
$100.0K Unknown
today